Close
24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.

Read the full press release published by the ALBA Synchrotron

More news

31/03/2016 ICN2 Graphene-Based Sensors for Biomedicine and Brain-Machine Interfaces 21/03/2016 Halal Certification Awarded to Natura Bissé 16/03/2016 SENER is back to Mars 09/03/2016 Barcelona, 2016/17 Top European City for FDI Strategy 03/03/2016 NCD Beamline at ALBA Synchrotron: When X-Rays Make Chocolate Speak 24/02/2016 Barcelona DC Cluster from BSP at the 2016 Mobile World Congress Brokerage Event
26 27 28 29 30 31 32 33 34 35 36